(MedPage Today) — BERLIN — A single infusion of the investigational PRAME-directed T-cell receptor T-cell therapy anzutresgene autoleucel (anzu-cel) showed encouraging antitumor activity in patients with previously treated advanced or metastatic…
Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118094
Author :
Publish date : 2025-10-22 21:23:00
Copyright for syndicated content belongs to the linked Source.
